Drug Shortage Report for DIPYRIDAMOLE INJECTION, USP
Report ID | 170977 |
Drug Identification Number | 02244475 |
Brand name | DIPYRIDAMOLE INJECTION, USP |
Common or Proper name | DIPYRIDAMOLE INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | DIPYRIDAMOLE |
Strength(s) | 5MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 mL |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-12-01 |
Actual start date | 2023-01-01 |
Estimated end date | 2023-03-31 |
Actual end date | 2023-02-28 |
Shortage status | Resolved |
Updated date | 2023-04-03 |
Company comments | Product on 100% allocation . |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-04-03 | French | Compare |
v9 | 2023-04-03 | English | Compare |
v8 | 2023-01-16 | French | Compare |
v7 | 2023-01-16 | English | Compare |
v6 | 2023-01-02 | French | Compare |
v5 | 2023-01-02 | English | Compare |
v4 | 2022-11-11 | English | Compare |
v3 | 2022-10-04 | English | Compare |
v2 | 2022-10-03 | French | Compare |
v1 | 2022-10-03 | English | Compare |
Showing 1 to 10 of 10